The Use of Dried Blood Spots for the Quantification of Antihypertensive Drugs.
Alexander Anatolievich ChernonosovPublished in: International journal of analytical chemistry (2018)
Hypertension or high blood pressure is a harbinger of cardiovascular diseases. There are several classes of drugs used to treat hypertension. This review discusses the use of dried blood spots (DBSs) for the quantification by mass spectrometry (MS), tandem mass spectrometry (MS/MS), or, in some cases, by fluorescence detection methods the following antihypertensive medications: angiotensin-converting enzyme inhibitors (ramipril, ramiprilat, captopril, and lisinopril); angiotensin II receptor antagonists (valsartan, irbesartan, losartan, and losartan carboxylic acid); calcium channel blockers (verapamil, amlodipine, nifedipine, pregabalin, and diltiazem); α blockers (guanfacine, doxazosin, and prazosin); β blockers (propranolol, bisoprolol, atenolol, and metoprolol); endothelin receptor antagonists (bosentan and ambrisentan); and statins (simvastatin, atorvastatin, and rosuvastatin).
Keyphrases
- angiotensin converting enzyme
- angiotensin ii
- blood pressure
- mass spectrometry
- tandem mass spectrometry
- liquid chromatography
- hypertensive patients
- high performance liquid chromatography
- ultra high performance liquid chromatography
- ms ms
- gas chromatography
- cardiovascular disease
- vascular smooth muscle cells
- simultaneous determination
- high resolution mass spectrometry
- heart rate
- high resolution
- solid phase extraction
- capillary electrophoresis
- liquid chromatography tandem mass spectrometry
- multiple sclerosis
- pulmonary arterial hypertension
- label free
- single molecule
- coronary artery disease
- energy transfer
- real time pcr
- adipose tissue